Pacific Biosciences
PACB
#6557
Rank
โ‚น64.86 B
Marketcap
โ‚น214.85
Share price
-5.16%
Change (1 day)
16.41%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2025 (TTM): โ‚น13.36 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น13.89 Billion. In 2024 the company made a revenue of โ‚น13.21 Billion a decrease over the revenue in the year 2023 that were of โ‚น16.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น13.36 B1.15%
2024 โ‚น13.21 B-20.85%
2023 โ‚น16.69 B57.23%
2022 โ‚น10.61 B9.29%
2021 โ‚น9.71 B68.36%
2020 โ‚น5.76 B-10.98%
2019 โ‚น6.48 B17.89%
2018 โ‚น5.49 B-7.88%
2017 โ‚น5.96 B-3.19%
2016 โ‚น6.16 B-0.02%
2015 โ‚น6.16 B60.55%
2014 โ‚น3.84 B120.59%
2013 โ‚น1.74 B22.37%
2012 โ‚น1.42 B-20.58%
2011 โ‚น1.79 B2288.09%
2010 โ‚น75.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
โ‚น385.47 B 2,673.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚น14.60 B 5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น3.950 T 28,329.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.931 T 28,192.06%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น301.82 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA